The Government Accountability Office (GAO) investigated the FDA’s foreign drug inspection program in the fall of 2007, and again from March through April of this year, and found that recent FDA initiatives, some which have been implemented and others proposed, could strengthen the FDA's foreign drug inspection program, but these initiatives do not fully address the weaknesses that the GAO had previously testified to in November 2007.
SOURCE: GAO Testimony
For more information on this and related topics, consult the CCH Food, Drug and Cosmetic Law Reporter.
Visit our News Library to read more news stories.
Food, Drug and Cosmetics Law Reporter
Everything you need to know about Food and Drug Regulations.Full-text source covering federal and state laws and regulations and court decisions that govern the safety, effectiveness, purity, packaging and labeling of food, drugs and cosmetics. Learn More » |
Medical Devices ReporterAccess the full text plus expert analysis of all laws and regulations governing the classification, approval, manufacture, and marketing of all medical diagnostic, and radiological devices. Learn More »
|